Shopping Cart
- Remove All
- Your shopping cart is currently empty
Clivatuzumab-MMAE, an antibody-drug conjugate (ADC), combines a MUC1-targeted antibody with Monomethyl auristatin E (MMAE) and is utilized in the research of pancreatic cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Clivatuzumab-MMAE, an antibody-drug conjugate (ADC), combines a MUC1-targeted antibody with Monomethyl auristatin E (MMAE) and is utilized in the research of pancreatic cancer. |
Alias | Anti-MUC1 Reference Antibody |
Molecular Weight | 145 kDa |
Storage | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.